Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: Relation to morphology, cell proliferation and expression of breast cancer-related genes

International Journal of Cancer

Volumn 89, Issue 5, 2000, Pages 403-410

  Fiche, Maryse ^a,d   Avet Loiseau, Hervé ^a   Maugard, Christine M ^b   Sagan, Christine ^a   Heymann, Marie Françoise ^a   Leblanc, Magali ^b   Classe, Jean Marc ^b   Fumoleau, Pierre ^b   Dravet, François ^b   Mahé, Marc ^b   Dutrillaux, Bernard ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b CENTRE RENÉ GAUDUCHEAU   (France)

^c INSTITUT CURIE   (France)

^d CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CARCINOMA IN SITU; CELL PROLIFERATION; CELL STRUCTURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONCOGENE MYC; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INFILTRATING DUCT; CELL DIVISION; CYCLIN D1; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; GENES, MYC; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGE; PROTO-ONCOGENES; SUPPORT, NON-U.S. GOV'T;

EID: 0033802222     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000920)89:5<403::AID-IJC2>3.0.CO;2-3     Document Type: Article

References (46)

1. Allelic loss of chromosomal arm 8p in breast cancer progression
2. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients
3. Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markers
4. Comparative genomic hybridization of ductal carcinoma in situ of the breast: Evidence of multiple genetic pathways
5. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region
6. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast
7. DNA amplifications at 20q13 and MDM2 define distinct subgroups of evolved breast and ovarian tumours
8. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumor: Definition of phenotypic groups
9. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification
10. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast
11. Immunohistochemical analysis of apocrine lesions. Consistent overexpression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ
12. Chromosome I aneusomy identified by interphase cytogenetics in mammographically detected ductal carcinoma in situ of the breast
13. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors
14. Ductal carcinoma in situ: A proposal for a new classification
15. Comparative genomic hybridization of ductal carcinoma in situ of the breast: Identification of regions of DNA amplification and deletion in common with invasive breast carcinoma
16. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization
17. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
18. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia
19. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53 c-erb B2 bcl-2 and Ki-67
20. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers
21. Wide-spread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS
22. Identification of amplified DNA sequences in breast cancer and their organization within homogeneously stained regions
23. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ
24. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis
25. Analysis of loss of heterozygoty in 399 premalignant breast lesions at 15 genetic loci
26. DNA analysis of in situ ductal carcinoma of the breast via flow cytometry
27. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification. Association between cellular proliferation and c-erbB protein expression
28. Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins
29. Allelotyping of ductal carcinoma in situ of the breast: Deletion of loci on 8p, 13q, 16q, 17p and 17q
30. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer
31. DNA flow cytometric analysis in ductal carcinoma in situ of the breast
32. p53 Protein expression and nuclear DNA content in breast intraductal proliferations
33. Prognostic classification of breast ductal carcinoma in situ
34. Amplification of CCND-1 and expression of its protein product cyclin dl in ductal carcinoma in situ of the breast
35. Molecular characterization of intraductal breast carcinomas
36. Molecular analysis of premalignant and carcinoma in situ lesions of the human breast
37. Loss of heterozygosity in ductal carcinoma in situ of the breast
38. Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes
39. Amplification of chromosomal region 20q13 in invasive breast cancer: Prognostic implications
40. Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia
41. Molecular cytogenetics of primary breast cancer by CGH
42. Correlation of numerical and structural status of chromosome 16 with histological type and grade of non-invasive and invasive breast carcinomas
43. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics
44. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis
45. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: Correlations with estrogen and progesterone receptors p53 and c-erbB-2 proteins and proliferative activity